Mobocertinib, Asciminib & Surufatinib Among Latest New Filings In EU

 
• By Neena Brizmohun

The European Medicines Agency has added nine new products to its latest list of medicines that are under review for potential EU marketing authorization.

Marketing applications for new drugs are under review in the EU. • Source: Alamy

More from Europe

More from Geography